Skip to main content
. 2008 Mar 14;14(1):83–93. doi: 10.1111/j.1527-3458.2007.00035.x

Figure 3.

Figure 3

Baseline‐to‐end point placebo‐ corrected, weighted mean differences (± 95% CI) in OFF time for entacapone and tolcapone. *The large 95% CI reflects the few placebo subjects in this analysis (n= 5) (Adler et al. 1998; Baas et al. 1997; Brooks and Sagar 2003; Kurth et al. 1997; Myllyla et al. 1997; Parkinson Study Group, 1997; Poewe et al. 2002; Rinne et al. 1998). PSG, Parkinson Study Group. (Data from Deane KH (Deane et al. 2004)).